The
Brazilian
Journal
of
INFECTIOUS
DISEASES
w w w .e l s e v i e r . c o m / l o c a t e / b j i d
Original
article
Inappropriate
surgical
chemoprophylaxis
and
surgical
site
infection
rate
at
a
tertiary
care
teaching
hospital
Devang
Ashwinkumar
Rana
∗,
Supriya
Deepak
Malhotra,
Varsha
Jitendra
Patel
DepartmentofPharmacology,Smt.N.H.LMuni,Medicalcollege,Ahmedabad,Gujarat,India
a
r
t
i
c
l
e
i
n
f
o
Articlehistory:
Received4August2012 Accepted6September2012 Availableonline1January2013
Keywords:
Kunin’scriteria Rationality
Surgicalchemoprophylaxis Surgicalsiteinfection(SSI)
a
b
s
t
r
a
c
t
Objectives:Thisstudyaimedtoanalyzethepatternofsurgicalchemoprophylaxis,surgical siteinfectionrate,andtocheckrationalityofsurgicalchemoprophylaxisbasedonKunin’s criteria.
Materialsandmethods:Aprospective,observationalstudywasperformedonpatients under-goingsurgery,inatertiarycareteachinghospital.Datawerecollectedinapro-formawhich includedthepatients’details,prescriptionsfromdateofadmissiontodischargeoranyother outcomeandoperativenotes.SurgicalsiteinfectionasdefinedbyCentreforDiseaseControl criteriawasrecorded.RationalitywasassessedbasedonKunin’scriteria.
Results:Total220patientswereenrolledoveraperiodofoneyear.Meanhospitalstaywas 8.67±5.17days. A totalof2294 drugswereprescribedout ofwhich840 (36.61%)were antimicrobials. Meanduration forpre-operativeintravenousantimicrobial therapywas 0.75±0.45dayandforpost-operative intravenousantimicrobialtherapywas3.33±2.24 dayswhile post-operativeoralantimicrobialtherapywas4.58±3.34days.Third genera-tioncephalosporinswereprescribedmostfrequently64.74%and64.40%pre-operativelyand post-operativelyrespectively.Antimicrobialprescribingwasinappropriatein52.28%.Total of19patientsdevelopedsurgicalsiteinfection.Surgicalsiteinfectionratewassignificantly higher(13.04%) inpatientsreceiving inappropriatechemoprophylaxis(p<0.01). Surgical siteinfectionadds9.98daysofhospitalstay(p<0.0001)and3.57extradrugs(p<0.0001) comparedtogroupwithoutsurgicalsiteinfection.
Conclusion:Inappropriateuseofantimicrobialsishighlyprevalentinsurgical chemoprophy-laxisleadingtohighersurgicalsiteinfectionrate.Adoptionofinternationalstandardand formulationoflocallyfeasibleguidelinescanhelpovercomethissituation.
©2013ElsevierEditoraLtda.Allrightsreserved.
Introduction
As Sir Alexander Fleming predicted in his Nobel Lecture, “Antimicrobials, sincetheir introduction have been pivotal
∗ Correspondingauthor.Tel.:+919426418842/07927622834.
E-mailaddresses:devangandu@gmail.com(D.A.Rana),supriyadmalhotra@gmail.com(S.D.Malhotra),drvarsha4@rediffmail.com
(V.J.Patel).
inthepreventionandtreatmentofinfections.However,the increasinguseofantimicrobialshasledtoasituationof appro-priateandinappropriateuse.”1Asurgicalsiteinfection(SSI)2
is aninfection that occurs aftersurgery inthe part ofthe body wherethe surgerytook place.Surgical site infections
1413-8670/$–seefrontmatter©2013ElsevierEditoraLtda.Allrightsreserved.
remainamongthemaincausesofpost-operativemorbidity, prolonginghospitalizationandincreasingthecostofmedical treatmentinsurgicalunits.3–4Antimicrobialsplayan
impor-tantroleinpreventingand treatingsurgicalsiteinfections. Surgicalchemoprophylaxisisanimportantmeasurebefore anysurgerytopreventSSI.Variousguidelines5–8areavailable
fortheuseofantimicrobialsforsurgicalchemoprophylaxis. Howeveritisobservedthattheyarenotalwaysfollowed.9,10
Thishasledtoaworldwideemergenceofantimicrobial resis-tance, a major public health problem and has significant impactontreatmentandoutcomes.Toproducethedesired effect, antimicrobialshaveto besafe, efficacious and have tobeusedrationally.Severalstudieshaveevaluatedpattern ofuse ofantimicrobials assurgical chemoprophylaxis, but thereare verylimitedstudiesinrecentyearsonevaluation ofrationality. Kunin’s criteria are rationality based evalua-tionofuseofantimicrobials.Thismethodologyisbasedon localprescribingpatternsandallowsforindividualevaluation ofeachprescriptionasopposedtodevelopinggeneral crite-ria/categoriesofinfectionsandappropriateantimicrobialuse toevaluatethequalityofprescribingbyaudits.Inthepast,the classificationwasmainlybasedontheauthorityofinfectious diseasesspecialistswhoperformedtheevaluation.11Several studieshavereportedSSIrateorpatternofsurgical chemo-prophylaxisbuthavenotcorrelatedSSIrateswithpatternof surgicalchemoprophylaxis.12–17
Thisstudy was undertaken toevaluatethe pattern and rationalityofantimicrobialdrugprescribingbysurgeons in perioperativepatientsusingKunin’scriteria.11 SSIratewas
calculatedand difference amongpatients withappropriate andinappropriatesurgicalchemoprophylaxiswasalso ana-lyzed.Theaimofthisstudywastoevaluatethecurrentpattern ofsurgicalchemoprophylaxisamongpatientsundergoing sur-gicalproceduresinatertiarycarehospitalanditsimpacton SSIrate.
Objectivesofstudy
1. Toassessthecurrentpatternofsurgicalchemoprophylaxis anditsrationalityassessmentbasedonKunin’scriteria11
and Scottish Intercollegiate Guidelines Network (SIGN)6 coreindicatorsforauditingantimicrobialuse insurgical chemoprophylaxis.
2. ToevaluatesurgicalsiteinfectionrateanddifferenceinSSI rateifanybetweenappropriateandinappropriate prescrip-tions.
Materials
and
methods
Twohundredandtwentyprescriptionsofpatientsadmitted inthe General Surgerywards ofa tertiary teaching hospi-talwerecollectedprospectivelybetweenJune2010andMay 2011.Thestudy protocol, pro-forma, and other documents likepatientinformationsheetandinformedconsentformin Englishandlocalvernacularlanguagewereapprovedby Insti-tutional Ethics Committee.All patientsundergoing surgery irrespectiveoftheirageandgenderwereincluded.Patients whowerenotwillingtogiveinformationwereexcludedfrom the study. Case records of enrolled patients, admitted for
Table1–Kunin’scriteria11forrationalityassessmentof
antimicrobialprescriptions.
CategoryI:Agreewiththeuseofantimicrobial therapy/prophylaxis,theprogramisappropriate
CategoryII:Agreewiththeuseofantimicrobial
therapy/prophylaxis,butapotentiallyfatalbacterialinfection cannotberuledoutorprophylaxisisprobablyappropriate, advantagesderivedremaincontroversial
CategoryIII:Agreewiththeuseofantimicrobial
therapy/prophylaxis,butadifferent(usuallylessexpensiveor toxic)antimicrobialispreferred
CategoryIV:Agreewiththeuseofantimicrobial
therapy/prophylaxis,butamodifieddoseisrecommended
CategoryV:Disagreewiththeuseofantimicrobial therapy/prophylaxis,administrationispreferred
CategoryVI:datacannotbejudgedbecauseofmissinginformation
any operative procedures were recorded in the pro-forma containingdemographicdetails,chiefcomplaints,diagnosis, details ofoperativeprocedures anddrugdetails duringthe hospital stay. Class of operationwas decided in consulta-tionwithoperatingsurgeonsandwasbasedonUSNational ResearchCouncilgroupcriteria.18SSIratewascalculatedas
defined byCDC,2 rationality assessmentwas done
accord-ingtotheKunin’scriteria11showninTable1basedonCDC
1999Guidelines5asreferencestandardandalsosurgicalaudit
based on SIGN guideline criteria.6 The analysis was done
basedonCDCguidelinesbecauseofunavailabilityofnational orlocalguidelines.Thegenericnamesofdrugs,generic con-tentsofeach formulationwere obtainedfrom thepatient’s pharmacybills.Drugsandformulationswhichwerenot men-tionedinthebillswereobtainedfromlocalpharmacystores andcommercialpublicationslikeIndianDrugReview2010and 2011.
Statisticalanalysis
DatawereanalyzedbyusingSPSS20.0demoversion®.Fisher’s exacttest(twotailed)wasusedtodeterminethesignificance ofSSIpositiveratesamongdifferentvariablesandunpaired
t-testwasusedtodeterminethedifferencebetweenthe inap-propriateandappropriateprescriptiongroups.Valueofp<0.05 wasconsideredasstatisticallysignificant.
Results
Atotalof220patientswereenrolled inthe studyofwhich 141(64.1%)weremales.Theagerangesfrom13to78years; with mean age 38.88±14.18(mean±S.D.). About 90%(197) underwent electivesurgeriestherest beingemergency sur-geries.Mostoftheoperativeprocedureswereopen207(94%) andtherestwerelaparoscopic.Generalanesthesiawasused in 8 patients and in the rest either spinal or local anes-thesiawas used.Herniorrhaphy(27.3%)and appendectomy (20.5%) remained the most frequentlyperformed operative procedures. Class I, i.e., clean surgeries 105 (47.73%) were mostfrequent,followedbyclassII,i.e.,clean-contaminated 53(24.09%),classIII-contaminated38(17.27%),andclass IV-dirty24(10.91%)asshowninTable2.Meanhospitalstaywas 8.67±5.17days(mean±S.D.).
Table2–Distributionofsurgeriesaccordingtoclass18andsurgicalsiteinfection(SSI)2rate.
Class Operativeprocedures % SSIpositivepatients %
Clean(I) 104 47.27 2 1.92
Cleancontaminated(II) 53 24.09 4 7.54
Contaminated(III) 39 17.72 3 7.69
Dirty(IV) 24 10.91 10 41.66
Total 220 100 19 8.64
Allthepatientsundergoingoperativeproceduresreceived singleintravenous dose of antimicrobial 30minbefore the surgery,followedbypost-operativeintravenoustherapyand furtheroraltherapywithantimicrobial.Meandurationfor pre-operativeintravenousantimicrobialtherapy was 0.75±0.45 days. Meanduration ofpost-operative intravenous antimi-crobial therapy was 3.33±2.24 while post-operative oral antimicrobialtherapywas4.58±3.34days.Noneofthe oper-ativeproceduresexceededmorethan4hduration.
A total of 2294 drugs were prescribed out of which 840(36.61%)wereantimicrobials.Ceftriaxone wasthemost frequently used antimicrobial pre-operatively (50.64%) and post-operatively(36.93%)asshowninFig.1.
Outof220patients,28hadsuspectedSSI.Nineteenpatients outof28hadmicrobiologicallyconfirmedSSI,Escherichiacoli
(9)andStaphylococcusaureus(7)beingthecommonpathogens. SSIratewashighestinclassIV(41.66%)followedbyinclassIII (7.69%),II(7.54%),andwasleastinclassI(1.92%).SSIratewas significantlyhigherinpatientswhopresentedwithdiabetes mellitus(p<0.0001)andhypertension(p=0.0048)asshownin
Table3.SSIpositiveratein61herniapatientswas2(1.63%)
whilein45appendectomypatientstheratewas1(2.22%).In thesepatientsE.coliwasthemostcommonisolate.Meanage ofSSIpositivepatientswasfoundsignificantlyhigheras com-paredtoSSInegativepatients(p<0.001)whichisdepictedin
Table3.Patientswithageabove40yearsshowedsignificant
higherSSIpositiverateascomparedtopatientslessthan40 years.TherewasnosignificantdifferenceforSSIratebetween gender,typesofanesthesiaandbetweenopenandlaproscopic surgery,whileemergencysurgeryshowedsignificantlyhigher SSIrateincomparisonwithelectivesurgery(p=0.0073).Mean
0 50 100 150 200 250 Pre-operative Post-operative Ceftriaxone MetronidazoleCefoperazone Amikacin Gentamicin Ampicillin + Cloxacillin Levofloxacin Cefixime + Clavulanic
CefuroximeCefiximeLinezolidMeropenam
Piperacillin + Tazbactum
Fig.1–Pre-operativeandpost-operativeantimicrobial drugs.
hospitalstayforSSInegativepatientswas7.81±4.1andthat forSSIpositivepatientwas17.79±6.41,whichshowsa signif-icantincreaseinmeanhospitalstayby9.98days(p<0.0001). Patients withhospitalstaygreaterthan aweekhad signif-icantly higherrate (p<0.0001) ofSSI positivity.Meandrugs prescribed inSSI negative were 7.43±1.74 and that in SSI positive patientwas11±2yieldingasignificant (p<0.0001) increaseof3.57drugs.
Antimicrobialprescriptionswerecategorizedas appropri-ate(IandII)–105(47.7%)andinappropriate(III,IV,andV)– 115(52.3%)basedonKunin’scriteria11asshowninTable4.
SSI rate was significantly higher (p<0.05), in inappropriate group(13.04%)incomparisonwithappropriategroup(3.8%)as showninTable4.Outof61herniapatients,19prescriptions wereinappropriateoutofwhich2patientshadSSI(p=0.0934). Outof45appendectomypatients35prescriptionswere inap-propriateandonepatienthasSSI(p=1).RateofSSIsinpatients who receive inappropriate prophylaxis (as defined by CDC guideline5)comparedwithrateofthis infectioninpatients
whoreceiveappropriateprophylaxis,expressedasaratiowas foundtobe3.43.Table5depictsthe processmeasuresand outcomemeasuresaccordingtoSIGNguidelines.6
Discussion
Thisstudywasaimedtoevaluatethecurrentprescribing pat-tern along with rationality, its impact on SSI rate and on hospital stay and number ofextra drugs needed. Previous studyfromPakistan12reported55.7%maleslowercompared
toours64%,meanageofthepatientswas35±17years,and somewhatlesscomparedtoourstudy,i.e.,38.8%.
In our study SSI rate was 8.64% which was similar to previousstudies.13 Inourstudy E.coliwasmostcommonly
isolated pathogen, followedby S.aureuswhich isin accor-dance withprevious Indian study.19 SSI rate fortwo most
commonlyperformedsurgeriesherniorrhaphyand appendec-tomyiscomparabletoanearlierstudycarriedoutinIndia14
and aworldwidemetaanalysisstudy.20 Thereisno
signifi-cantdifference inSSIrate betweengenders,this findingis similartoapreviousstudyreportedinIranin2006.21SSIrate
increaseswithageabove40years,whichwasstatistically sig-nificantatp<0.0001andwassimilartostudyreportedfrom India.22SSIrateamongpatientsreceivinggeneralanesthesia
inourstudywas16.67%ascomparedtoothermodes(7.92%), whichisinaccordancewithpreviousstudydoneinUK.23SSI
ratewashigherinemergencysurgerythaninelectiveandis comparabletoanotherIndianstudy.14InourstudySSIrate
wassignificantlyhigherindiabeticandhypertensivepatients whichwasalsoseeninapreviousIndianstudy.22Inourstudy
Table3–Surgicalsiteinfection(SSI)rates2andvariables.
SSInegative(n=201) SSIpositive(n=19) Total(n=220) pvaluea
Meanage 37.71±13.44 51.26±16.21 38.88±14.19 <0.0001 ≤40years 134 6 140 0.0047 >40years 67 13 80 Gender Male 131 10 141 0.32 Female 70 9 79
Daysofhospitalstay 7.81±4.1 17.79±6.41 8.67±5.17 <0.0001
≤7days 118 1 119
>7days 83 18 101
No.ofdrugsgiven 7.43±1.74 11±2 10.42±3.37 <0.0001
Typeofanesthesia General 15 3 18 0.193 OtherSAandLA 186 16 202 Modeofoperation Elective 184 13 197 0.0073 Emergency 17 6 23 Open 188 19 207 0.60 Laproscopic 13 0 13 Co-morbidconditionsb Diabetesmellitus 2 9 11 <0.0001 Hypertension 10 5 15 0.0048
UsingFischer’sexacttwotailedtestandunpairedt-test. a p<0.005.
b Fourpatientspresentedwithbothdiabetesandhypertension.
opensurgery.AstudybyJawienetal.15reportedlessSSIrate
inlaproscopicsurgerythaninopensurgery.SSIledto signifi-cantlyextendedhospitalstay(9.98days)whichissimilartoa Europeanstudy(1998)24whichreported9.8days.
Inourstudy asinglepre-operativedoseofantimicrobial therapy was given before the operative procedure which isin accordance with the various standard guidelines and previousstudiesalsoshowedthatsingledoseprophylaxisis notassociatedwithincreasedrateofSSIwhencomparedto multipledoseregimens.25Inourstudymeandurationof
pre-operativeintravenoustherapywas0.75±0.45days,followed bymean post-operativeintravenous therapy for 3.33±2.24 andpost-oporaltherapyfor4.58±3.34days.Howevertiming ofadministrationoffirstdoseofantimicrobialpre-operatively wasincompliancewiththeCDCguidelines.5Meanduration
of post-operative antimicrobial use was 7.88 days which islonger thanreportedbyprevious studyfromIndia, i.e.,5
days16whichmaybeduetodifferencesinprevalentpractices.
Allpatientsreceivedantimicrobials,inboththepre-operative andpost-operativeperiod,andnoantimicrobialwasgivenin theintra-operativeperiod.Mostcommonlyuseddruggroup forprophylaxiswasthirdgenerationcephalosporins,followed bymetronidazole,andpenicillingroupsimilartoanIndian study.17Inourstudynoneofthepatientsreceivedcefazolin
asrecommendedbyvariousguidelines.5–8
Forsurgicalprophylaxisitisimportanttoselectan antimi-crobialwithnarrowestantibacterialspectrumtoreducethe emergence ofresistance,secondlytheantimicrobial antibi-otic must be active against the most likely contaminating microorganismsforthattypeofsurgery,thefirst-generation cephalosporinsare excellentagentsforskinandsofttissue infections owing to Streptococcus pyogenes and methicillin-susceptible S.aureus. Hencea singledose ofcefazolin just before surgery is the preferred prophylaxis for procedures
Table4–AppropriatenessofsurgicalprophylaxisbasedonKunin’scriteria11andsurgicalsiteinfectionrate(n=220).
Appropriatetherapy
CategoryI CategoryII Subtotal SSIpositive SSInegative
2(0.91%) 103(46.81%) 105(47.72%) 4 101
Inappropriatetherapy
CategoryIII CategoryIV CategoryV Subtotal SSIpositive SSInegative
108(49.09%) 0(0%) 7(3.19%) 115(52.28%) 15 100
Table5–CoreindicatorsforsurgicalauditbasedonSIGNguidelines.6
(a)Processmeasures
1 Wasprophylaxisgivenforanoperationincludedinlocalguidelines? Nolocalguidelineavailable
2 Ifprophylaxiswasgivenforanoperationnotincludedinlocalguidelines, wasaclinicaljustificationforprophylaxisrecordedinthecasenotes?
Justificationwasnotrecordedinthecasenote
3 Wasthefirstdosageofprophylaxisgivenwithin30minofthestartof surgery?
Yes
4 Werethechoice,dosageandrouteofadministrationconsistentwithlocal guidelinesforthatprocedure?
Consistentwithoutguideline
5 Wastheprescriptionwritteninthe“once-only”sectionofthedrug prescriptionchart?
Notapplicable
6 Wasthedurationofprophylaxisgreaterthen24h? Yes (b)Outcomemeasures
1 Surgicalsiteinfectionrate=numberofSSIsoccurring postoperatively/totalnumberofoperativeprocedures
19/220=0.0864(8.64%) 2 RateofSSIsoccurringpostoperativelyinpatientswhoreceive
inappropriateprophylaxis(asdefinedinguideline)comparedwithrateof thisinfectioninpatientswhoreceiveappropriateprophylaxis,expressed asaratio
13.04/3.8=3.43
3 RateofClostridiumdifficileinfectionsoccurringpostoperativelyinpatients whoreceiveinappropriateprophylaxis(asdefinedinguideline)compared withrateofthisinfectioninpatientswhoreceiveappropriate
prophylaxis,expressedasaratio
NoculturerecordedClostridiumdifficile infection
in which skin flora are the likely pathogens. For patients undergoingclean operativeprocedure for herniorrhaphy, a cleanprocedureasingledoseofcefazolin1gpreoperatively andforappendectomy,acleancontaminatedsurgerysingle preoperativeintravenousdoseofeithercefotetanorcefoxitin 1g is recommended.5–8 Therefore, it is recommended that
the use of third generation cephalosporins such as ceftri-axoneandcefotaximebeavoidedinsurgicalprophylaxisas it may berequired later if patient developsserious sepsis For herniorrhaphyuse ofcefazolinis appropriate,whilein caseofappendectomythirdgenerationcephalosporinshave been used as substitutefor cefotetan and cefoxitin in our study asinIndia cefazolinisavailablewhilecefotetanand cefoxitinarenotmarketed.26Howeverthisisnotjustified,as thirdgeneration cephalosporinshavetobesparedfor ther-apeuticpurpose.Better optionwould beanalternativelike cefuroxime.Dirtyandcontaminatedsurgeriesrequiredbroad spectrum antimicrobials coverage. Drugs like piperacillin, tazobactum,linezolidwereusedmainlyafterdiagnosisofSSI fortherapeuticpurpose.
Inourstudy52%patientsreceivedinappropriate chemo-prophylaxis according to Kunin’s criteria.11 This finding is
inaccordancewithearlierstudiesthatshowed51.5%11and
65.6%27 respectively.Mostoftheantimicrobialswere broad
spectrum,prescribedforlongerdurationwhichwas unwar-ranted.Inappropriateprophylaxiswasassociatedwithhigher culturepositive(SSIpositive)rates(13.04%)ascomparedtothe appropriateprophylaxis(3.8%).
Toourknowledgethis studyisfirst ofitskind inIndia. Strength of this study was the assessment of rationality ofchemoprophylaxis based on Kunin’scriteria11 and SIGN
guideline6aswellascomparisonofSSIrateinpatients
receiv-ingappropriateandinappropriatechemoprophylaxis.Oneof thelimitationsofourstudy iscross-sectionaldesignofthe study.Alsotherewasnopatientfollowupafterdischargeup to30dayswhichisrequiredaccordingtoCDCdefinitionofSSI andhencesomecasesofSSIafterdischargefromhospitalmay
bemissed.Patientpost-dischargequestionnairewasnotused andfurtheranalysisbasedonqualityoflifecouldbedone. Fur-therstudieswithlargersamplesizecanbeplannedincluding additionalcostbornebythepatientbecauseof inappropriate-ness.Indepthsubanalysisintovarioustypesofsurgeriesand variousdrugregimensandinfectionscanbedonetoselecta properandrationalregimenforanindividualsurgeryusing otherguidelines.Kunin’scriteria11isapreliminaryevaluation
ofappropriateness,afurtherin-depthanalysisof antimicro-bialprescriptioncanbedoneaccordingtotheModifiedKunin’s criteria,25Giessenscore,28andbySWABsscore.29Evaluation
basedonthecombinedscoresfromboththesurgicalwound judgmentandprescriptionanalysiscanalsobedone.
Conclusion
Inappropriate chemoprophylaxisasevidentinthis studyis associatedwithhigherSSIrateleadingtoprolongationof hos-pital stay and increasednumber of drugs usage. Adoption ofinternationalstandardandformulationoflocallyfeasible guidelinescanhelpovercomethissituation.Howeverthisis a singlecenter study andresults ofthisstudy may notbe generalized.
Conflict
of
interest
Theauthorshavenoconflictofinteresttodeclare.
Acknowledgements
TheauthorswouldliketoexpresstheirthankstoDr.PankajR. Patel,Dean,Smt.NHLMedicalCollegeandDr.M.H.Makwana, Superintendent,V.S.Hospitalforpermittingthemtodothis work inV.S.Hospital. Theauthorsalsoexpressgratitudeto surgerydepartmentforsupport.
r
e
f
e
r
e
n
c
e
s
1. FlemingA.Penicillin.Nobellecture.1945.Availableat
http://www.nobelprize.
org/medicine/laureates/1945/fleming-lecture.pdf.06[accessed01.08.12].
2. MangramAJ,HoranTC,PearsonML,SilverLC,JarvisWR. Guidelineforpreventionofsurgicalsiteinfection;1999. Availableathttp://www.cdc.gov/hicpac/SSI/001SSI.html
[accessed01.08.12].
3. RehospitalizationsAfterTreatmentforSSIAdd$10Millionto $65MilliontoHealthcareCosts.Availableathttp://www. infectioncontroltoday.com/news/2012/06/rehospitalizations-
after-treatment-for-ssi-add-10-to-65-million-to-healthcare-costs.aspx[accessed01.08.12].
4. PerencevichEN,SandsKE,CosgroveSE,etal.Health andeconomicimpactofsurgicalsiteinfectionsdiagnosed afterhospitaldischarge.EmergInfectDis.2003;9:196–203. 5. MangramAJ,HoranTC,PearsonML,SilverLC,JarvisWR.
Guidelineforpreventionforofsurgicalsiteinfection;1999. Availableathttp://www.cdc.gov/hicpac/pdf/guidelines/
SSI1999.pdf[accessed01.08.12].
6. RoyalCollegeofPhysicians.Antibioticprophylaxisinsurgery. Anationalclinicalguideline.Edinburgh:Scottish
IntercollegiateGuidelinesNetwork;2000,2008update available:www.sign.ac.uk/guidelines/fulltext/45/index.html
[accessed01.08.12].
7. NationalCollaboratingCentreforWomen’sandChildren’s Health,CommissionedbytheNationalInstituteforHealth andClinicalExcellence.Surgicalsiteinfection:prevention andtreatmentofsurgicalsiteinfection.Availableat
http://www.nice.org.uk/nicemedia/pdf/CG74NICEGuideline. pdf[accessed01.08.12].
8. AmericanSocietyofHealthSystemPharmacistguidelines. Availableathttp://www.ashp.org/sashp/docs/files/BP07/
TGSurgical.pdf[accessed01.08.12].
9. RosarioMO,Pe ˜naAC,AmpilIDE.Adherencetosurgical antimicrobialprophylaxisguidelinesinatertiaryprivate medicalcenter.PhilJMicrobiolInfectDis.2010;39:51–8. 10.vanKasterenMEE,KullbergBJ,deBoerAS,Mintjes-deGrootJ,
GyssensIC.Adherencetolocalhospitalguidelinesfor surgicalantimicrobialprophylaxis:amulticentreauditin Dutchhospitals.JAntimicrobChemother.2003;51:1389–96. 11.KuninCM,TupasiT,CraigWA.Useofantimicrobials.Abrief
expositionoftheproblemandsometentativesolutions.Ann InternMed.1973;79:555–60.
12.BibiS,ChannaAG,SiddiquiTR,AhmedW.Frequencyandrisk factorsofsurgicalsiteinfectionsingeneralsurgerywardofa tertiarycarehospitalofKarachi,Pakistan.IntJInfectControl. 2011;7:1–5.Availableathttp://www.ijic.info/article/view/
6093/6140[accessed01.08.12].
13.AnvikarAR,DeshmukhAB,KaryakarteRP,etal.Oneyear prospectivestudyof3280surgicalwounds.IndianJMed Microbiol.1999;17:129–32.
14.PatelDA,PatelKB,BhattSK,ShahHS.Surveillanceofhospital acquiredinfectioninsurgicalwardsintertiarycarecentre Ahmedabad,Gujarat.NatlJCommunMed.2011;2:340–5. 15.JawienM,Wojkowska-MachJ,RozanskaA,BulandaM,
HeczkoPB.Surgicalsiteinfectionfollowingcholecystectomy: comparisonofproceduresperformedwithandwithouta laparoscope.IntJInfectControl.2008;4:1–5.
16.RehanHS,KakkarAK,GoelS.Patternofsurgicalantibiotic prophylaxisinatertiarycareteachinghospitalinIndia.IntJ InfectControl.2010;6:1–5.
17.RazaviSM,IbrahimpurM,KashaniAS,JafarianA.Abdominal surgicalsiteinfections:incidenceandriskfactorsatan Iranianteachinghospital.BMCSurg.2005;5:1–5. 18.BerardF,GandonJ.Postoperativewoundinfections:the
influenceofultravioletirradiationoftheoperatingroom andofvariousotherfactors.AnnSurg.1964;160Suppl.1:1– 192.
19.PatelSM,PatelMH,PatelSD,SoniST,KinariwalaDM,Vegad MM.Surgicalsiteinfections:incidenceandriskfactorsina tertiarycarehospital,westernIndia.NatlJCommunMed. 2012;3:193–6.
20.SanabriaA,DomínguezLC,ValdiviesoE,GómezG. Prophylacticantibioticsformeshinguinalhernioplasty:a meta-analysis.AnnSurg.2007;245:392–6.
21. AskarianM,MoravvejiAR,MirkhaniH,NamaziS,WeedH. AdherencetoAmericanSocietyofHealth-System
Pharmacistssurgicalantimicrobialprophylaxisguidelinesin Iran.InfectControlHospEpidemiol.2006;27:876–8.
22.SuchitraJoyceB,LakshmideviN.Surgicalsiteinfections: assessingriskfactors,outcomesandantimicrobialsensitivity patterns.AfrJMicrobiolRes.2009;3:175–9.
23.LeeJS,HayangaAJ,KubusJJ,MakepeaceH,HuttonM, CampbellJrDA.Localanesthesia:astrategyforreducing surgicalsiteinfections?WorldJSurg.2011;35:2596–602. 24.DiPiroJT,MartindaleRG,BakstA,VacaniPF,WatsonP,Miller
MT.Infectioninsurgicalpatients:effectsonmortality, hospitalization,andpostdischargecare.AmJHealthSyst Pharm.1998;55:777–81.
25.VanDeerMeerJWM,VanKasterenM.Improvingprescribing insurgicalprophylaxis.In:GouldIM,vanderMeerJWM, editors.Antibioticpolicies:theoryandpractice.1sted.New York,USA:Springer;2005.p.185–226.
26.MalikA,MalikS.IndianDrugReviewCompendium.1sted. India:MediworldPublications;2011.
27. DettenkoferM,ForsterDH,EbnerW,etal.Thepracticeof perioperativeantimicrobialprophylaxisineightGerman hospitals.Infection.2002;30:164–7.
28.WillemsenI,GroenhuijzenA,BogaersD,StuurmanA,van KeulenP,KluytmansJ.Appropriatenessofantimicrobial therapymeasuredbyrepeatedprevalencesurveys. AntimicrobAgentsChemother.2007;51:864–7. 29.VanKasterenMEE,MannienJ,KullbergBJ,etal.Quality
improvementofsurgicalprophylaxisinDutchhospitals: evaluationofamulti-siteinterventionbytimeseries analysis.JAntimicrobChemother.2005;56:1094–102.